SEC Form 4/A · accession 0001127602-17-026366
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Kelly A. Kramer
Director
Period of report
Aug 19, 2017
Accepted (ET)
Aug 23, 2017 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2017 | M | 1,339 | — | A | 1,339 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F3,F2 | — | Aug 19, 2017 | M | 1,339 | D | — | — | Common Stock | 1,339 | 2,241 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F2100% of the restricted stock units vested on August 19, 2017.
- F3The original Form 4 filed on August 22, 2017 is amended by this Form 4/A to restate the number of derivative securities beneficially owned following the reported transaction(s). No other changes have been made to the original Form 4.